Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1133034

Case series of COVID-19 in patients with myasthenia gravis: a single institution experience


Županić, Sven; Perić Šitum, Martina; Majdak, Maja; Karakaš, Mirna; Bašić, Silvio; Sporiš, Davor
Case series of COVID-19 in patients with myasthenia gravis: a single institution experience // Acta neurologica Belgica, 121 (2021), 4; 1039-1044 doi:10.1007/s13760-021-01662-w (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1133034 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Case series of COVID-19 in patients with myasthenia gravis: a single institution experience

Autori
Županić, Sven ; Perić Šitum, Martina ; Majdak, Maja ; Karakaš, Mirna ; Bašić, Silvio ; Sporiš, Davor

Izvornik
Acta neurologica Belgica (0300-9009) 121 (2021), 4; 1039-1044

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
COVID-19 ; immunosuppression ; myasthenia gravis ; neuromuscular disorders ; SARS-CoV-2

Sažetak
Coronavirus disease 2019 (COVID-19), caused by the late 2019 outbreak of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes a respiratory disease which could put myasthenia gravis patients at a greater risk of developing severe disease course. This paper presents a single-institution case series of hospitalized myasthenia gravis patients with COVID 19. We identified eight patients previously diagnosed with myasthenia gravis, four of whom presented with clear signs of myasthenia gravis symptom worsening on admission. No form of respiratory support was needed during the complete duration of stay for three patients, oxygen therapy was administered to two patients, while the remaining three patients required mechanical ventilation. Treatment was successful for seven patients, six of whom were discharged without any myasthenia gravis symptoms. One patient died after eleven days of intensive care unit treatment. Although treatment of patients with myasthenia gravis and COVID-19 patients is challenging, case series of myasthenia gravis patients with COVID-19 treated in our institution demonstrates relatively favorable treatment outcome. Our data seem to support the notion that immunosuppressive medication does not seem to result in worse outcomes. Our data also support the notion that intravenous immunoglobulin treatment is safe and should be administered to patients with myasthenia gravis and COVID-19 in case of myasthenia gravis worsening since benefits seem to greatly outweigh the risks.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Klinička bolnica "Dubrava",
Fakultet za dentalnu medicinu i zdravstvo, Osijek

Profili:

Avatar Url Sven Županić (autor)

Avatar Url Davor Sporiš (autor)

Avatar Url Silvio Bašić (autor)

Poveznice na cjeloviti tekst rada:

doi link.springer.com

Citiraj ovu publikaciju:

Županić, Sven; Perić Šitum, Martina; Majdak, Maja; Karakaš, Mirna; Bašić, Silvio; Sporiš, Davor
Case series of COVID-19 in patients with myasthenia gravis: a single institution experience // Acta neurologica Belgica, 121 (2021), 4; 1039-1044 doi:10.1007/s13760-021-01662-w (međunarodna recenzija, članak, znanstveni)
Županić, S., Perić Šitum, M., Majdak, M., Karakaš, M., Bašić, S. & Sporiš, D. (2021) Case series of COVID-19 in patients with myasthenia gravis: a single institution experience. Acta neurologica Belgica, 121 (4), 1039-1044 doi:10.1007/s13760-021-01662-w.
@article{article, author = {\v{Z}upani\'{c}, Sven and Peri\'{c} \v{S}itum, Martina and Majdak, Maja and Karaka\v{s}, Mirna and Ba\v{s}i\'{c}, Silvio and Spori\v{s}, Davor}, year = {2021}, pages = {1039-1044}, DOI = {10.1007/s13760-021-01662-w}, keywords = {COVID-19, immunosuppression, myasthenia gravis, neuromuscular disorders, SARS-CoV-2}, journal = {Acta neurologica Belgica}, doi = {10.1007/s13760-021-01662-w}, volume = {121}, number = {4}, issn = {0300-9009}, title = {Case series of COVID-19 in patients with myasthenia gravis: a single institution experience}, keyword = {COVID-19, immunosuppression, myasthenia gravis, neuromuscular disorders, SARS-CoV-2} }
@article{article, author = {\v{Z}upani\'{c}, Sven and Peri\'{c} \v{S}itum, Martina and Majdak, Maja and Karaka\v{s}, Mirna and Ba\v{s}i\'{c}, Silvio and Spori\v{s}, Davor}, year = {2021}, pages = {1039-1044}, DOI = {10.1007/s13760-021-01662-w}, keywords = {COVID-19, immunosuppression, myasthenia gravis, neuromuscular disorders, SARS-CoV-2}, journal = {Acta neurologica Belgica}, doi = {10.1007/s13760-021-01662-w}, volume = {121}, number = {4}, issn = {0300-9009}, title = {Case series of COVID-19 in patients with myasthenia gravis: a single institution experience}, keyword = {COVID-19, immunosuppression, myasthenia gravis, neuromuscular disorders, SARS-CoV-2} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font